TREA

90481362 - T T-DETECT

Follow

Information

  • Trademark
  • 90481362
  • Serial Number
    90481362
  • Filing Date
    January 22, 2021
    4 years ago
  • Transaction Date
    September 11, 2023
    a year ago
  • Status Date
    September 11, 2023
    a year ago
  • Published for Opposition Date
    December 13, 2022
    2 years ago
  • Location Date
    February 07, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MICHELI, ANGELA M
  • Attorney Docket Number
    10214-00502-
    Attorney Name
    Hoang-chi Truong
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
T T-DETECT
Case File Statements
  • DM0000: The mark consists of a capitalized letter "T" in stylized form, underneath which is the word "T-Detect".
  • GS0051: Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
  • GS0441: Medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services related to the treatment of persons; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing.
  • GS0421: Development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immunedisorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples
Case File Event Statements
  • 9/11/2023 - a year ago
    26 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 9/11/2023 - a year ago
    25 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 2/7/2023 - a year ago
    24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/13/2022 - 2 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/13/2022 - 2 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/23/2022 - 2 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/7/2022 - 2 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/3/2022 - 2 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/3/2022 - 2 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/3/2022 - 2 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/3/2022 - 2 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/11/2022 - 2 years ago
    15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/11/2022 - 2 years ago
    14 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/11/2022 - 2 years ago
    13 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/5/2022 - 2 years ago
    12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 3/8/2022 - 2 years ago
    11 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 2/24/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/1/2022 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/31/2022 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/31/2022 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/30/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/30/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/30/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/20/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/23/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/26/2021 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP